AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Nov 17, 2011
34519_dirs_2011-11-17_b53dfad0-7cb0-4bf4-9d3d-f485f61a2a1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-11-16
Reporting Person: BRIGHAM MICHAEL F (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-11-16 | Common Stock | D | 618 | $5.17 | Disposed | 154252 | Direct |
| 2011-11-16 | Common Stock | M | 1000 | $3.2 | Acquired | 155252 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-16 | Incentive stock options (right to buy) | $3.2 | M | 1000 | Disposed | 2011-12-10 | common stock (1000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23